Berlin, Germany

John S Andrews

This inventor holds 2 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1991-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John S Andrews. Retrieved from https://idiyas.com/inventor/john-s-andrews-vceg60z8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Berlin, DE (1991)
  • EP, Oss, NL (1993)

Company Filing History:


Years Active: 1991-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: John S. Andrews: Innovator in Pharmaceutical Chemistry

Introduction

John S. Andrews is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on beta-carbolines and their derivatives. With a total of 2 patents to his name, Andrews has established himself as a key figure in his industry.

Latest Patents

Andrews' latest patents focus on beta-carbolines, detailing a process for their production and their use in N-hetaryl imidazole derivatives. These derivatives are characterized by a general formula that showcases their potential applications in various pharmaceutical contexts.

Career Highlights

Throughout his career, John S. Andrews has been associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical sector. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Andrews has collaborated with esteemed colleagues such as Ralph Schmiechen and Dieter Rahtz. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

John S. Andrews is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the industry. His contributions through patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…